Medical technology firm Masimo has started marketing its Pronto Pulse CO-Oximeter with next generation SpHb Spot Check technology outside the US.
The Next Generation Pronto features rainbow SET technology which enables functionalities including non-invasive spot checking of total hemoglobin (SpHb), oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI).
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The SpHb technology offers a non-invasive and a continuous monitoring of total haemoglobin in the blood.
It is incorporated in Pronto to enable motion tolerance and a time reduction of 40% to display SpHb result ensuring an improved accuracy in the range of 6 to 11 g/dL.
Masimo founder and CEO Joe Kiani said: "This is a significant enhancement to the noninvasive measurement we introduced seven years ago.
"Since then, all of the clinical outcome studies we are aware of on our continuous SpHb technology have been positive,1-3 which is something that couldn’t be said for standard pulse oximetry before the introduction of Masimo SET SpO2.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData"We will continue to improve SpHb until it has the same measure-through motion and low-perfusion performance as our SET SpO2 technology."
Masimo’s Pronto will also be complemented with rainbow DCI-mini reusable sensor, which can also be used on children weighed greater than 3kg.
The rainbow DCI-mini uses a lightweight ribbon cable to connect to Pronto and a digit clip that is attached to a small child’s finger or on an infant’s big toe or thumb.
Image: A view of Pronto Pulse CO-Oximeter with Next Generation SpHb and rainbow DCI-mini Reusable Sensor. Photo: courtesy of Business Wire.
